<DOC>
	<DOCNO>NCT01915849</DOCNO>
	<brief_summary>The purpose study assess effect LIK066 intestinal glucose absorption immediately single dose ( immediate effect ) 6 hour follow dose ( multiple daily dos ; sustain effect ) patient type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>Effect LIK066 Glucose Absorption Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients , age 1865 year , must diagnose T2DM least 6 month prior screen HbA1c 6.5 10.0 % , inclusive , screen . Fasting plasma glucose â‰¤250mg/dL screening . If treat metformin , patient must stable dose 12 week prior randomization maintain dose end study . Patients type 1 diabetes mellitus . Patients history acute diabetic complication within 6 month prior screen . Pregnant nursing ( lactate ) woman . Women childbearing potential unless use effective method contraception dose study treatment . Patients sign symptom significant diabetic complication . Patients treat certain blood pressure lipid lower medication unless patient stable dos 12 week prior dose . History drug alcohol abuse within 12 month prior dose . Any surgical medical condition , acute unstable chronic disease may , base investigator 's opinion , jeopardize patient case participation study . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>